Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: Developing treatments using an integrated translational approach

World Journal of Biological Psychiatry

Volumn 15, Issue 2, 2014, Pages 84-95

  MacHado Vieira, Rodrigo ^a,b   Soeiro De Souza, Marcio G ^b   Richards, Erica M ^a   Teixeira, Antonio L ^c   Zarate Jr , Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Uveitis Section   (Brazil)

Author keywords

Bipolar disorder; Brain; Depression; Neurobiology; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; ANKYRIN; CALCIUM; CALCIUM CHANNEL L TYPE; CHOLINE; CREATINE; CREATINE PHOSPHATE; CYTOKINE; DIACYLGLYCEROL KINASE; GLUCOCORTICOID; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; INOSINE PHOSPHATE; INOSITOL; KETAMINE; LACTIC ACID; LITHIUM; MK 0657; MOOD STABILIZER; N ACETYLASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE CELL ADHESION MOLECULE; NEUROCAN; NEUROTRANSMITTER; NEUROTROPHIN; NORADRENALIN; PROTEIN KINASE C; RILUZOLE; TAMOXIFEN; UNCLASSIFIED DRUG; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; BEHAVIOR; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BRAIN MITOCHONDRION; COGNITION; DIAGNOSTIC VALUE; DNA POLYMORPHISM; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; HEREDITY; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MANIA; MEDLINE; MICROARRAY ANALYSIS; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; REVIEW; SECOND MESSENGER; SYNAPSE; TRANSLATIONAL RESEARCH; WHITE MATTER LESION; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIPOLAR DISORDER; HUMANS; NEURONAL PLASTICITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84893828878     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.830775     Document Type: Review

References (94)

1. Akimoto T , Kusumi I , Suzuki K , Koyama T. 2007. Effects of calmodulin and protein kinase C modulators on transient Ca2-increase and capacitative Ca2-entry in human platelets: relevant to pathophysiology of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31 : 136-141.
2. Andreazza AC , Kauer-Sant'Anna M , Frey BN , Bond DJ , Kapczinski F , Young LT , et al. 2008. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Dis 111 : 135-144.
3. Andreazza AC , Wang JF , Salmasi F , Shao L , Young LT. Specifi c subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 20 May 2013.
4. Angelucci F , Aloe L , Jim é nez-Vasquez P , Math é AA. 2003. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol 6 : 225-231. (Pubitemid 37248000)
5. Baum AE , Akula N , Cabanero M , Cardona I , Corona W , Klemens B , et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13 : 197-207.
6. Beaulieu J-M , Gainetdinov RR , Caron MG. 2009. Akt/GSK3 signaling in the action of psychotropic drugs. Ann Rev Pharmacol Toxicol 49 : 327-347.
7. Benedetti F , Serretti A , Pontiggia A , Bernasconi A , Lorenzi C , Colombo C , et al. 2005. Long-term response to lithium salts in bipolar illness is infl uenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci Lett 376 : 51-55. (Pubitemid 40202936)
8. Berk M , Kapczinski F , Andreazza AC , Dean OM , Giorlando F , Maes M , et al. 2011. Pathways underlying neuroprogression in bipolar disorder: focus on infl ammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35 : 804-817.
9. Berman RM , Cappiello A , Anand A , Oren DA , Heninger GR , Charney DS , et al. 2000. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 : 351-354. (Pubitemid 30109248)
10. Bora E , Fornito A , Y ü cel M , Pantelis C. 2010. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 67 : 1097-1105.
11. Brennan BP , Hudson JI , Jensen JE , McCarthy J , Roberts JL , Prescot AP , et al. 2010. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35 : 834-846.
12. Chen G , Zeng WZ , Yuan PX , Huang LD , Jiang YM , Zhao ZH , et al. 1999b. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72 : 879-882. (Pubitemid 29055256)
13. Clay HB , Sillivan S , Konradi C. 2011. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 29 : 311-324.
14. Cotter DR , Pariante CM , Everall IP. 2001. Glial cell abnormalities in major psychiatric disorders: the evidence and implications . Brain Res Bull 55 : 585-595. (Pubitemid 32888377)
15. Craddock N , Sklar P. 2009. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 25 : 99-105.
16. Cui J , Shao L , Young LT , Wang JF. 2007. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144 : 1447-1453. (Pubitemid 46123817)
17. Dager SR , Friedman SD , Parow A , Demopulos C , Stoll AL , Lyoo IK , et al. 2004. Brain metabolic alterations in medicationfree patients with bipolar disorder. Arch Gen Psychiatry 61 : 450-458. (Pubitemid 38620843)
18. de Sousa RT , van de Bilt MT , Diniz BS , Ladeira RB , Portela LV , Souza DO , et al. 2011. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 494 : 54-56.
19. Debette S , Markus HS. 2010. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J 341 : c3666.
20. Deep-Soboslay A , Iglesias B , Hyde TM , Bigelow LB , Imamovic V , Herman MM , et al. 2008. Evaluation of tissue collection for postmortem studies of bipolar disorder. Bipolar Disord 10 : 822-828.
21. Diazgranados N , Zarate CA. 2008. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder. Curr Psychiatry Rep 10 : 510-519.
22. DiazGranados N , Ibrahim LA , Brutsche NE , Ameli R , Henter ID , Luckenbaugh DA , et al. 2010. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 71 : 1605-1611.
23. Dokucu ME , Yu L , Taghert PH. 2005. Lithium-and valproateinduced alterations in circadian locomotor behavior in Drosophila . Neuropsychopharmacology 30 : 2216-2224. (Pubitemid 41643972)
24. Drevets WC , Price JL , Simpson JR , Todd RD , Reich T , Vannier M , et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 : 824-827. (Pubitemid 27181254)
25. Frizzo ME , Dall'Onder LP , Dalcin KB , Souza DO. 2004. Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol 24 : 123-128. (Pubitemid 38233735)
26. Genoux D , Montgomery JM. 2007. Glutamate receptor plasticity at excitatory synapses in the brain. Clin Exp Pharmacol Physiol 34 : 1058-1063. (Pubitemid 47274556)
27. Gigante AD , Young LT , Yatham LN , Andreazza AC , Nery FG , Grinberg LT , et al. 2011. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14 : 1075-1089.
28. Goodwin FK , Jamison KR. 2007. Manic-depressive illness: Bipolar and recurrent unipolar disorders. New York: Oxford University Press.
29. Grande I , Fries GR , Kunz M , Kapczinski F. 2010. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investg 7 : 243-250.
30. Hashimoto K , Koizumi H , Nakazato M , Shimizu E , Iyo M. 2005. Role of brain-derived neurotrophic factor in eating disorders: recent fi ndings and its pathophysiological implications. Prog Neuropsychopharmacol Biol Psychiatry 29 : 499-504. (Pubitemid 40603822)
31. Hashimoto K , Sawa A , Iyo M. 2007. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62 : 1310-1316. (Pubitemid 350060893)
32. Hirayasu Y , Shenton ME , Salisbury DF , Kwon JS , Wible CG , Fischer IA , et al. 1999. Subgenual cingulate cortex volume in fi rst-episode psychosis. Am J Psychiatry 156 : 1091-1093. (Pubitemid 29302806)
33. Ibrahim L , Diazgranados N , Franco-Chaves J , Brutsche N , Henter ID , Kronstein P , et al. 2012a. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, doubleblind, placebo-controlled study. Neuropsychopharmacology 37 : 1526-1533.
34. Ibrahim L , Diaz Granados N , Jolkovsky L , Brutsche N , Luckenbaugh DA , Herring WJ , et al. 2012b. A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol. 32 : 551-557.
35. Jope RS. 2011. Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci 4 : 16.
36. Jope RS , Roh M-S. 2006. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7 : 1421-1434. (Pubitemid 44718302)
37. Kakiuchi C , Iwamoto K , Ishiwata M , Bundo M , Kasahara T , Kusumi I , et al. 2003. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35 : 171-175. (Pubitemid 37187636)
38. Kapczinski F , Frey BN , Kauer-Sant'Anna M , Grassi-Oliveira R. 2008. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 8 : 1101-1113. (Pubitemid 351962077)
39. Kato T , Ishiwata M , Mori K , Washizuka S , Tajima O , Akiyama T , et al. 2003. Mechanisms of altered Ca2-signalling in transformed lymphoblastoid cells from patients with bipolar disorder . Int J Neuropsychopharmacol 6 : 379-389.
40. Kato T , Takahashi S , Shioiri T , Inubushi T. 1993. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 27 : 53-59. (Pubitemid 23029240)
41. Kato T , Takahashi S , Shioiri T , Murashita J , Hamakawa H , Inubushi T. 1994. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31 : 125-133. (Pubitemid 24183900)
42. Kempton MJ , Geddes JR , Ettinger U , Williams SCR , Grasby PM. 2008. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 65 : 1017-1032.
43. Khairova R , Pawar R , Salvadore G , Juruena MF , de Sousa RT , Soeiro-de-Souza MG , et al. 2012. Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep 5 : 680-682.
44. Konradi C , Sillivan SE , Clay HB. 2012. Mitochondria, oligodendrocytes and infl ammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 45 : 37-47.
45. Kraguljac NV , Reid M , White D , Jones R , den Hollander J , Lowman D , et al. 2012. Neurometabolites in schizophrenia and bipolar disorder-a systematic review and meta-analysis. Psychiatry Res 203 : 111-125.
46. Li X , Jope RS. 2010. Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35 : 2143-2154.
47. Lim CS , Baldessarini RJ , Vieta E , Yucel M , Bora E , Sim K. 2013. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: Review of the evidence. Neurosci Biobehav Rev.
48. Liu ME , Huang CC , Yang AC , Tu PC , Yeh HL , Hong CJ , et al. 2013. Effect of Bcl-2 rs956572 polymorphism on age-related gray matter volume changes. PLoS One 8:e56663.
49. Lyoo IK , Sung YH , Dager SR , Friedman SD , Lee J-Y , Kim SJ , et al. 2006. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 8 : 65-74. (Pubitemid 43356022)
50. Machado-Vieira R , Andreazza AC , Viale CI , Zanatto V , Cereser V , da Silva Vargas R , et al. 2007a. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421 : 33-36. (Pubitemid 46908861)
51. Machado-Vieira R , Dietrich MO , Leke R , Cereser VH , Zanatto V , Kapczinski F , et al. 2007b. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61 : 142-144. (Pubitemid 46072782)
52. Machado-Vieira R , Manji HK , Zarate CA. 2009a. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2) : 92-109.
53. Machado-Vieira R , Salvadore G , Diazgranados N , Zarate CA Jr. 2009b. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 123 : 143-50.
54. Machado-Vieira R , Pivovarova NB , Stanika RI , Yuan P , Wang Y , Zhou R , et al. 2011. The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry 69 : 344-352.
55. Machado-Vieira R , Ibrahim L , Henter ID , Zarate CA Jr. 2012. Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol Biochem Behav 100 : 678-87.
56. Maddock RJ , Buonocore MH. 2012. MR Spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci 1 Feb [Epub ahead of print].
57. Merikangas KR , Akiskal HS , Angst J , Greenberg PE , Hirschfeld RMA , Petukhova M , et al. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64 : 543-552. (Pubitemid 46718287)
58. Mizuta I , Ohta M , Ohta K , Nishimura M , Mizuta E , Kuno S. 2001. Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett 310 : 117-120. (Pubitemid 32822818)
59. Mocchetti I , Brown M. 2008. Targeting neurotrophin receptors in the central nervous system. CNS Neurol Disord Drug Targets 7 : 71-82. (Pubitemid 351516218)
60. Moore GJ , Cortese BM , Glitz DA , Zajac-Benitez C , Quiroz JA , Uhde TW , et al. 2009. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 70 : 699-705.
61. Munkholm K , Vinberg M , Berk M , Kessing LV. 2012. Staterelated alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disord 14 : 684-696.
62. Nierenberg AA , Kansky C , Brennan BP , Shelton RC , Perlis R , Iosifescu DV. 2013. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Aust NZ J Psychiatry 47 : 26-42.
63. Nurnberger JI , Foroud T. 2000. Genetics of bipolar affective disorder. Curr Psychiatry Rep 2 : 147-157.
64. Ongur D , Jensen JE , Prescot AP , Stork C , Lundy M , Cohen BM , et al. 2008. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 64 : 718-726.
65. Peng TI , Jou MJ. 2010. Oxidative stress caused by mitochondrial calcium overload. Ann NY Acad Sci 1201 : 183-188.
66. Port JD , Unal SS , Mrazek DA , Marcus SM. 2008. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Res 162 : 113-121.
67. Psychiatric GWAS Consortium Bipolar Disorder Working Group. 2011. Large-scale genome-wide association analysis of bipolar disorder identifi es a new susceptibility locus near ODZ4. Nat Genet 43 : 977-983.
68. Quiroz JA , Gray NA , Kato T , Manji HK. 2008. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33 : 2551-2565.
69. Quiroz JA , Machado-Vieira R , Zarate CA Jr, Manji HK. 2010. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62 : 50-60.
70. Schneider MR , DelBello MP , McNamara RK , Strakowski SM , Adler CM. 2012. Neuroprogression in bipolar disorder. Bipolar Disord 14 : 356-374.
71. Scott LJ , Muglia P , Kong XQ , Guan W , Flickinger M , Upmanyu R , et al. 2009. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci USA 106 : 7501-7506.
72. Seifuddin F , Mahon PB , Judy J , Pirooznia M , Jancic D , Taylor J , et al. 2012. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 159B : 508-518.
73. Selemon LD , Rajkowska G. 2003. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr Mol Med 3 : 427-436. (Pubitemid 36980562)
74. Shao L , Young LT , Wang J-F. 2005. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58 : 879-884. (Pubitemid 41790716)
75. Shao L , Sun X , Xu L , Young LT , Wang J-F. 2006. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci 78 : 1317-1323. (Pubitemid 43199952)
76. Sharma V , Menon R , Carr TJ , Densmore M , Mazmanian D , Williamson PC. 2003. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder . J Affect Disord 77 : 167-171. (Pubitemid 37363345)
77. Skaper SD. 2008. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 7 : 46-62. (Pubitemid 351516216)
78. So J , Warsh JJ , Li PP. 2007. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder . Biol Psychiatry 62 : 141-147. (Pubitemid 46963251)
79. Soeiro-de-Souza MG , Dias VV , Figueira ML , Forlenza OV , Gattaz WF , Zarate CA , et al. 2012. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand 126 : 332-341.
80. Sourial-Bassillious N , Rydelius P-A , Aperia A , Aizman O. 2009. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 161 : 1126-1134.
81. Szabo ST , Machado-Vieira R , Yuan P , Wang Y , Wei Y , Falke C , et al. 2009. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56 : 47-55.
82. Torgerson CM , Irimia A , Leow AD , Bartzokis G , Moody TD , Jennings RG , et al. 2013. DTI tractography and white matter fi ber tract characteristics in euthymic bipolar I patients and healthy control subjects. Brain Imaging Behav 7 : 129-139.
83. Vederine F-E , Wessa M , Leboyer M , Houenou J. 2011. A metaanalysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 35 : 1820-1826.
84. Weber H , Kittel-Schneider S , Gessner A , Domschke K , Neuner M , Jacob CP , et al. 2011. Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology 36 : 2076-2085.
85. Yan X-B , Hou H-L , Wu L-M , Liu J , Zhou J-N. 2007. Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia. Neuropharmacology 53 : 487-495. (Pubitemid 47284182)
86. Yin L , Wang J , Klein PS , Lazar MA. 2006. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 311 : 1002-1005. (Pubitemid 43271727)
87. Y ü ksel C , Ongur D. 2010. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 68, 85-794.
88. Zarate CA , Manji HK. 2009. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 23 : 569-582.
89. Zarate CA , Quiroz JA , Singh JB , Denicoff KD , De Jesus G , Luckenbaugh DA , et al. 2005. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57 : 430-432. (Pubitemid 40215774)
90. Zarate CA , Singh J , Manji HK. 2006a. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59 : 1006-1020. (Pubitemid 43849653)
91. Zarate CA , Singh JB , Carlson PJ , Brutsche NE , Ameli R , Luckenbaugh DA , et al. 2006b. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 : 856-864. (Pubitemid 44188478)
92. Zarate CA , Singh JB , Carlson PJ , Quiroz J , Jolkovsky L , Luckenbaugh DA , et al. 2007. Effi cacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9 : 561-570. (Pubitemid 47365623)
93. Zarate CA Jr, Machado-Vieira R , Henter I , Ibrahim L , Diazgranados N , Salvadore G. 2010. Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 18 : 293-303.
94. Zarate CA Jr, Brutsche NE , Ibrahim L , Franco-Chaves J , Diazgranados N , Cravchik A , et al. 2012. Replication of ketamine's antidepressant effi cacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71 : 939-46.